Onyx Pharmaceuticals Announces a Webcast and Teleconference to Provide an Update on BAY 43-9006
— Oct. 23, 2004
Contact:
Julie Wood
510-262-8757
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will host a conference call on Monday, October 25, 2004 at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time) to provide an update on BAY 43-9006.
Interested parties may access the live presentation at:
http://audioevent.mshow.com/191809
or by dialing 706-679-4614 and using the passcode 1770179. A replay of the presentation will be available on the Onyx website or by dialing 706-645-9291 and using the passcode 1770179 approximately three hours after the teleconference concludes. The replay will be available through November 25, 2004.
Onyx Pharmaceuticals is engaged in the development of novel cancer
therapies that target the molecular basis of cancer. With its collaborators,
the company is developing small molecule drugs, including BAY 43-9006 with
Bayer Pharmaceuticals Corporation. For more information about Onyx's
pipeline and activities, visit the company's website at
http://www.onyx-pharm.com.
Back to 2004 Press Releases
